Abstract 690: A Dual apoC-II mimetic-apoC-III Antagonist Peptide for Lowering Plasma Triglycerides

Anna Wolska,Larry Lo,Denis Sviridov,Mohsen Pourmousa,Milton Pryor,Ghosh Soumitra Shanker,Rahul Kakkar,Michael H. Davidson,Sierra Wilson,Richard W. Pastor,Jingrong Tang,Marcelo Amar,Matt Devalaraja,Alan T. Remaley

Abstract 690: A Dual apoC-II mimetic-apoC-III Antagonist Peptide for Lowering Plasma Triglycerides

2019

Anna Wolska
Larry Lo
Denis Sviridov
Mohsen Pourmousa
Milton Pryor
Ghosh Soumitra Shanker
Rahul Kakkar
Michael H. Davidson
Sierra Wilson
Richard W. Pastor
Jingrong Tang
Marcelo Amar
Matt Devalaraja
Alan T. Remaley

Epidemiological and genetic studies have established hypertriglyceridemia as causally related to cardiovascular disease, making it an active area for drug development. We describe a new strategy fo...

Keywords:

Antagonist
Internal medicine
Medicine
Hypertriglyceridemia
apoc iii
Endocrinology
Peptide
Drug development

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations